CRYM logo

Cryomass Technologies Inc. (CRYM)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cryomass Technologies Inc. (CRYM) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 57/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 17. März 2026
57/100 KI-Bewertung

Cryomass Technologies Inc. (CRYM) Gesundheitswesen & Pipeline-Uebersicht

CEOChristian Noel
Mitarbeiter6
HauptsitzDenver, US
IPO-Jahr2014

Cryomass Technologies Inc. designs and commercializes cryo-mechanical systems for handling harvested hemp and cannabis, positioning itself in the specialty drug manufacturing sector. The company focuses on providing equipment solutions for the efficient processing of high-value plants, operating with a small team in a niche market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Cryomass Technologies Inc. presents a high-risk, high-reward investment profile due to its focus on a niche market within the cannabis and hemp industries. The company's gross margin of 100.0% indicates potential for profitability if sales volume increases substantially. However, the negative profit margin of -95602.1% highlights significant operational challenges. Key growth catalysts include expanding market penetration in the cannabis and hemp processing sectors and developing new applications for its cryo-mechanical systems. The company's small size and limited resources pose risks, particularly in a competitive landscape. Investors should carefully consider the company's financial stability and ability to execute its growth strategy.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Cryomass Technologies Inc. operates with a small team of 6 employees, indicating a lean operational structure.
  • The company's gross margin is reported at 100.0%, suggesting high potential profitability on sales.
  • The company's profit margin is -95602.1%, indicating substantial losses.
  • Cryomass Technologies Inc. was re-branded in August 2021 to focus on cryo-mechanical systems.
  • The company's beta is -0.18, suggesting a low correlation with overall market movements.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Specialized technology for cryo-mechanical processing
  • Focus on the growing cannabis and hemp industries
  • High gross margin potential
  • Innovative solutions for plant handling

Schwaechen

  • Small company with limited resources
  • Negative profit margin
  • Reliance on a niche market
  • Limited brand recognition

Katalysatoren

  • Ongoing: Expansion of cannabis and hemp legalization in new regions.
  • Ongoing: Increasing demand for high-quality cannabis products.
  • Upcoming: Potential partnerships with cannabis cultivators and processors.
  • Upcoming: Development of new applications for cryo-mechanical systems.
  • Ongoing: Technological advancements in cryo-mechanical processing.

Risiken

  • Potential: Competition from larger, more established companies.
  • Potential: Changing regulations in the cannabis industry.
  • Potential: Economic downturns affecting the cannabis market.
  • Potential: Technological advancements rendering current systems obsolete.
  • Ongoing: Limited financial resources and negative profit margin.

Wachstumschancen

  • Expansion into New Geographies: Cryomass Technologies Inc. can pursue growth by expanding its sales and marketing efforts into new geographic markets where cannabis and hemp cultivation are legal and growing. This includes targeting states within the U.S. and countries internationally that have progressive cannabis regulations. The global cannabis market is projected to reach $47 billion by 2027, providing a significant opportunity for Cryomass to increase its market share by establishing a presence in key regions.
  • Development of New Product Applications: Cryomass Technologies Inc. can invest in research and development to create new applications for its cryo-mechanical systems beyond the processing of hemp and cannabis. This could include adapting the technology for use in other agricultural sectors or for processing other high-value plants. Diversifying its product applications would reduce the company's reliance on the cannabis industry and open up new revenue streams.
  • Strategic Partnerships and Collaborations: Cryomass Technologies Inc. can form strategic partnerships and collaborations with other companies in the cannabis and hemp industries, such as cultivators, processors, and distributors. These partnerships could provide access to new customers, distribution channels, and technology. Collaborating with established players in the industry would enhance Cryomass's credibility and accelerate its growth.
  • Focus on Technological Innovation: Cryomass Technologies Inc. can maintain a competitive edge by continuously innovating and improving its cryo-mechanical systems. This includes investing in research and development to enhance the efficiency, reliability, and scalability of its products. Staying at the forefront of technological advancements would attract new customers and retain existing ones.
  • Capitalizing on the Growing Demand for High-Quality Cannabis Products: As the cannabis industry matures, there is an increasing demand for high-quality cannabis products that are free from contaminants and retain their potency. Cryomass Technologies Inc.'s cryo-mechanical systems can help cultivators and processors meet this demand by providing a solution for preserving the quality of harvested plants. By emphasizing the benefits of its technology for producing high-quality cannabis products, Cryomass can attract customers who are willing to pay a premium for superior results.

Chancen

  • Expansion into new geographic markets
  • Development of new product applications
  • Strategic partnerships and collaborations
  • Capitalizing on the demand for high-quality cannabis products

Risiken

  • Competition from larger, more established companies
  • Changing regulations in the cannabis industry
  • Economic downturns affecting the cannabis market
  • Technological advancements rendering current systems obsolete

Wettbewerbsvorteile

  • Specialized cryo-mechanical technology
  • Focus on the cannabis and hemp processing market
  • Early mover advantage in a niche market

Ueber CRYM

Cryomass Technologies Inc., headquartered in Denver, Colorado, specializes in the design, sale, and commercialization of cryo-mechanical systems tailored for the handling of harvested hemp, cannabis, and other high-value plants. Originally incorporated in 2011 as Andina Gold Corp., the company transitioned its focus and rebranded as Cryomass Technologies Inc. in August 2021, signaling a strategic shift towards the burgeoning cannabis and hemp processing industry. The company's core offering revolves around providing innovative equipment solutions that leverage cryogenic technology to efficiently process and preserve the quality of harvested plants, catering to the specific needs of cultivators and processors in this sector. Cryomass Technologies Inc. operates with a compact team of six employees, reflecting its current scale and stage of development within the market. The company aims to establish itself as a key provider of specialized equipment for optimizing plant handling processes in the rapidly evolving cannabis and hemp industries.

Was das Unternehmen tut

  • Designs cryo-mechanical systems for plant processing.
  • Sells cryo-mechanical systems to cultivators and processors.
  • Commercializes cryo-mechanical systems for harvested hemp.
  • Commercializes cryo-mechanical systems for harvested cannabis.
  • Offers solutions for handling high-value plants.
  • Provides equipment for the cannabis and hemp industries.

Geschaeftsmodell

  • Sells cryo-mechanical systems to cannabis and hemp processors.
  • Generates revenue through equipment sales.
  • Focuses on providing specialized solutions for plant handling.

Branchenkontext

Cryomass Technologies Inc. operates within the specialty drug manufacturing sector, specifically targeting the cannabis and hemp processing market. This industry is characterized by rapid growth and evolving regulations. The competitive landscape includes companies like GENPF, IGEX, KAYS, KOAN, and LVVV, which offer various solutions for cannabis cultivation and processing. Cryomass Technologies Inc. aims to differentiate itself through its specialized cryo-mechanical systems. The overall market for cannabis processing equipment is expected to grow, driven by increasing legalization and demand for cannabis-based products.

Wichtige Kunden

  • Cannabis cultivators
  • Hemp processors
  • Companies involved in high-value plant processing
KI-Zuversicht: 67% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Cryomass Technologies Inc. (CRYM) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CRYM verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CRYM.

Kursziele

Wall-Street-Kurszielanalyse fuer CRYM.

MoonshotScore

57/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CRYM auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Christian Noel

Unknown

Information about Christian Noel's professional background is not available in the provided data. Therefore, a detailed biography cannot be provided. Further research would be required to ascertain his career history, education, and previous roles before joining Cryomass Technologies Inc.

Erfolgsbilanz: Due to the lack of available information regarding Christian Noel's background and tenure at Cryomass Technologies Inc., it is not possible to assess his track record, key achievements, or strategic decisions made under his leadership. Further data is needed to evaluate his performance and contributions to the company.

CRYM OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cryomass Technologies Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited operating history, are thinly traded, and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, manipulation, and lack of transparency.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Given that Cryomass Technologies Inc. trades on the OTC Other market, liquidity is likely to be very limited. This means that trading volume may be low, and the bid-ask spread may be wide, making it difficult to buy or sell shares at a desired price. Investors may experience significant price slippage and may not be able to exit their positions quickly.
OTC-Risikofaktoren:
  • Limited liquidity due to low trading volume
  • Lack of regulatory oversight and financial transparency
  • Potential for fraud and manipulation
  • Higher price volatility compared to exchange-listed stocks
  • Limited access to capital and financing options
Sorgfaltspruefung-Checkliste:
  • Verify the company's legal status and registration.
  • Obtain and review the company's financial statements, if available.
  • Assess the company's management team and their experience.
  • Research the company's business model and competitive landscape.
  • Evaluate the company's risk factors and potential liabilities.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimitaetssignale:
  • Company is registered and incorporated.
  • Company has a website and contact information.
  • Company has a business plan and strategy.
  • Company has a physical office location.
  • Company has a team of employees.

Was Anleger ueber Cryomass Technologies Inc. (CRYM) wissen wollen

What are the key factors to evaluate for CRYM?

Cryomass Technologies Inc. (CRYM) currently holds an AI score of 57/100, indicating moderate score. Key strength: Specialized technology for cryo-mechanical processing. Primary risk to monitor: Potential: Competition from larger, more established companies.. This is not financial advice.

How frequently does CRYM data refresh on this page?

CRYM prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CRYM's recent stock price performance?

Recent price movement in Cryomass Technologies Inc. (CRYM) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized technology for cryo-mechanical processing. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CRYM overvalued or undervalued right now?

Determining whether Cryomass Technologies Inc. (CRYM) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CRYM?

Before investing in Cryomass Technologies Inc. (CRYM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CRYM to a portfolio?

Potential reasons to consider Cryomass Technologies Inc. (CRYM) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Specialized technology for cryo-mechanical processing. Additionally: Focus on the growing cannabis and hemp industries. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CRYM?

Yes, most major brokerages offer fractional shares of Cryomass Technologies Inc. (CRYM) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CRYM's earnings and financial reports?

Cryomass Technologies Inc. (CRYM) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CRYM earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited financial data available for Cryomass Technologies Inc.
  • OTC market investments carry higher risk.
  • Lack of analyst coverage.
Datenquellen

Popular Stocks